Aurinia Pharmaceuticals's total assets for Q3 2024 were $549.36M, an increase of 4.93% from the previous quarter. AUPH total liabilities were $161.36M for the fiscal quarter, a 1.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.